{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,6]],"date-time":"2026-11-06T23:21:21Z","timestamp":1794007281415,"version":"4.8.0"},"reference-count":38,"publisher":"Elsevier BV","issue":"8","license":[{"start":{"date-parts":[[2024,8,1]],"date-time":"2024-08-01T00:00:00Z","timestamp":1722470400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2024,8,1]],"date-time":"2024-08-01T00:00:00Z","timestamp":1722470400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2024,4,14]],"date-time":"2024-04-14T00:00:00Z","timestamp":1713052800000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"content-domain":{"domain":["clinicalkey.fr","clinicalkey.jp","clinicalkey.es","clinicalkey.com.au","clinicalkey.com","celltherapyjournal.org","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Cytotherapy"],"published-print":{"date-parts":[[2024,8]]},"DOI":"10.1016\/j.jcyt.2024.03.480","type":"journal-article","created":{"date-parts":[[2024,4,10]],"date-time":"2024-04-10T03:04:15Z","timestamp":1712718255000},"page":"825-831","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":35,"title":["Safety and potential efficacy of expanded mesenchymal stromal cells of bone marrow and umbilical cord origins in patients with chronic spinal cord injuries: a phase I\/II study"],"prefix":"10.1016","volume":"26","author":[{"given":"Abdalla","family":"Awidi","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Abdulrahman","family":"Al Shudifat","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nael","family":"El Adwan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mahmoud","family":"Alqudah","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Fatima","family":"Jamali","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Fathy","family":"Nazer","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Halla","family":"Sroji","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hady","family":"Ahmad","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nahla","family":"Al-Quzaa","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-6088-8783","authenticated-orcid":false,"given":"Hanan","family":"Jafar","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.jcyt.2024.03.480_bib0001","unstructured":"World Health Organization. Spinal cord injury. Available at http:\/\/www.who.int\/mediacentre\/factsheets\/fs384\/en\/Accessed. [accessed 01. 28. 2023]."},{"key":"10.1016\/j.jcyt.2024.03.480_bib0002","doi-asserted-by":"crossref","first-page":"964","DOI":"10.1038\/sc.2017.56","article-title":"The impact of spinal cord injury on the quality of life of primary family caregivers: a literature review","volume":"55","author":"Lynch","year":"2017","journal-title":"Spinal Cord"},{"issue":"2","key":"10.1016\/j.jcyt.2024.03.480_bib0003","doi-asserted-by":"crossref","first-page":"659","DOI":"10.3390\/ijms21020659","article-title":"Emanuela Mazzon Stem cells therapy for spinal cord injury: an overview of clinical trials","volume":"21","author":"Silvestro","year":"2020","journal-title":"International Journal of Molecular Sciences"},{"issue":"7","key":"10.1016\/j.jcyt.2024.03.480_bib0004","doi-asserted-by":"crossref","first-page":"609","DOI":"10.1038\/sj.bmt.1705757","article-title":"Bone marrow-derived mesenchymal stromal cells for the repair of central nervous system injury","volume":"40","author":"Parr","year":"2007","journal-title":"Bone Marrow Transplant"},{"issue":"8\u20139","key":"10.1016\/j.jcyt.2024.03.480_bib0005","doi-asserted-by":"crossref","first-page":"675","DOI":"10.3727\/000000006783464381","article-title":"Autologous bone marrow transplantation in patients with subacute and chronic spinal cord injury","volume":"15","author":"Sykov\u00e1","year":"2006","journal-title":"Cell transplant"},{"issue":"4","key":"10.1016\/j.jcyt.2024.03.480_bib0006","doi-asserted-by":"crossref","first-page":"562","DOI":"10.1093\/neuros\/nyx250","article-title":"Emerging safety of intramedullary transplantation of human neural stem cells in chronic cervical and thoracic spinal cord injury","volume":"82","author":"Levi","year":"2018","journal-title":"Neurosurgery"},{"issue":"11","key":"10.1016\/j.jcyt.2024.03.480_bib0007","doi-asserted-by":"crossref","first-page":"3994","DOI":"10.3390\/ijms21113994","article-title":"Clinical trials of stem cell treatment for spinal cord injury","volume":"21","author":"Yamazaki","year":"2020","journal-title":"Int J Mol Sci"},{"issue":"2","key":"10.1016\/j.jcyt.2024.03.480_bib0008","doi-asserted-by":"crossref","first-page":"146","DOI":"10.1016\/j.jcyt.2020.08.008","article-title":"Clinical effects of intrathecal administration of expanded Wharton jelly mesenchymal stromal cells in patients with chronic complete spinal cord injury: a randomized controlled study","volume":"23","author":"Albu","year":"2021","journal-title":"Cytotherapy"},{"issue":"14","key":"10.1016\/j.jcyt.2024.03.480_bib0009","doi-asserted-by":"crossref","first-page":"7435","DOI":"10.3390\/ijms22147435","article-title":"Current concepts of stem cell therapy for chronic spinal cord injury","volume":"22","author":"Suzuki","year":"2021","journal-title":"Int J Mol Sci"},{"issue":"1","key":"10.1016\/j.jcyt.2024.03.480_bib0010","doi-asserted-by":"crossref","first-page":"178","DOI":"10.1186\/s12967-021-02843-0","article-title":"Transplantation of mesenchymal stem cells for spinal cord injury: a systematic review and network meta-analysis","volume":"19","author":"Chen","year":"2021","journal-title":"J Transl Med"},{"key":"10.1016\/j.jcyt.2024.03.480_bib0011","doi-asserted-by":"crossref","first-page":"897","DOI":"10.3109\/14653240903253857","article-title":"Exvivo-expanded autologous bone marrow-derived mesenchymal stromal cells in human spinal cord injury\/paraplegia: a pilot clinical study","volume":"11","author":"Pal","year":"2009","journal-title":"Cytotherapy"},{"key":"10.1016\/j.jcyt.2024.03.480_bib0012","doi-asserted-by":"crossref","first-page":"935","DOI":"10.1016\/j.clineuro.2012.02.003","article-title":"Clinical safety and primary efficacy of bone marrow mesenchymal cell transplantation in subacute spinal cord injured patients","volume":"114","author":"Karamouzian","year":"2012","journal-title":"Clin Neurol Neurosurg"},{"key":"10.1016\/j.jcyt.2024.03.480_bib0013","doi-asserted-by":"crossref","first-page":"73","DOI":"10.1016\/j.brainres.2013.08.016","article-title":"Transplantation of autologous bone marrow mesenchymal stem cells in the treatment of complete and chronic cervical spinal cord injury","volume":"1533","author":"Dai","year":"2013","journal-title":"Brain Res"},{"key":"10.1016\/j.jcyt.2024.03.480_bib0014","doi-asserted-by":"crossref","first-page":"140","DOI":"10.3892\/etm.2013.1083","article-title":"A clinical trial report of autologous bone marrow-derived mesenchymal stem cell transplantation in patients with spinal cord injury","volume":"6","author":"Jiang","year":"2013","journal-title":"Exp Ther Med"},{"key":"10.1016\/j.jcyt.2024.03.480_bib0015","doi-asserted-by":"crossref","first-page":"729","DOI":"10.3727\/096368913X664540","article-title":"Autologous bone marrow-derived cell therapy combined with physical therapy induces functional improvement in chronic spinal cord injury patients","volume":"23","author":"El-Kheir","year":"2014","journal-title":"Cell Transplant"},{"key":"10.1016\/j.jcyt.2024.03.480_bib0016","doi-asserted-by":"crossref","first-page":"126","DOI":"10.1186\/scrt516","article-title":"Safety and neurological assessments after autologous transplantation of bone marrow mesenchymal stem cells in subjects with chronic spinal cord injury","volume":"5","author":"Mendon\u00e7a","year":"2014","journal-title":"Stem Cell Res. Ther."},{"issue":"3","key":"10.1016\/j.jcyt.2024.03.480_bib0017","doi-asserted-by":"crossref","first-page":"436","DOI":"10.1227\/NEU.0000000000001056","article-title":"A phase III clinical trial showing limited efficacy of autologous mesenchymal stem cell therapy for spinal cord injury","volume":"78","author":"Oh","year":"2016","journal-title":"Neurosurgery"},{"key":"10.1016\/j.jcyt.2024.03.480_bib0018","doi-asserted-by":"crossref","first-page":"518","DOI":"10.1016\/j.jcyt.2016.01.004","article-title":"Autologous mesenchymal stromal cell transplantation for spinal cord injury: a phase I pilot study","volume":"18","author":"Satti","year":"2016","journal-title":"Cytotherapy"},{"key":"10.1016\/j.jcyt.2024.03.480_bib0019","doi-asserted-by":"crossref","first-page":"1025","DOI":"10.1016\/j.jcyt.2016.05.003","article-title":"An approach to personalized cell therapy in chronic complete paraplegia: the Puerta de Hierro phase I\/II clinical trial","volume":"18","author":"Vaquero","year":"2016","journal-title":"Cytotherapy"},{"key":"10.1016\/j.jcyt.2024.03.480_bib0020","doi-asserted-by":"crossref","first-page":"1189","DOI":"10.1016\/j.jcyt.2017.06.006","article-title":"Image-guided percutaneous intralesional administration of mesenchymal stromal cells in subjects with chronic complete spinal cord injury: a pilot study","volume":"19","author":"Larocca","year":"2017","journal-title":"Cytotherapy"},{"key":"10.1016\/j.jcyt.2024.03.480_bib0021","doi-asserted-by":"crossref","first-page":"349","DOI":"10.1016\/j.jcyt.2016.12.002","article-title":"Repeated subarachnoid administrations of autologous mesenchymal stromal cells supported in autologous plasma improve quality of life in patients suffering incomplete spinal cord injury","volume":"19","author":"Vaquero","year":"2017","journal-title":"Cytotherapy"},{"key":"10.1016\/j.jcyt.2024.03.480_bib0022","doi-asserted-by":"crossref","first-page":"796","DOI":"10.1016\/j.jcyt.2018.04.006","article-title":"Cell therapy with autologous mesenchymal stromal cells in post-traumatic syringomyelia","volume":"20","author":"Vaquero","year":"2018","journal-title":"Cytotherapy"},{"key":"10.1016\/j.jcyt.2024.03.480_bib0023","doi-asserted-by":"crossref","first-page":"445","DOI":"10.1186\/s13287-021-02515-2","article-title":"Combining cell therapy with human autologous Schwann cell and bone marrow-derived mesenchymal stem cell in patients with subacute complete spinal cord injury: safety considerations and possible outcomes","volume":"12","author":"Oraee-Yazdani","year":"2021","journal-title":"Stem Cell Res Ther"},{"key":"10.1016\/j.jcyt.2024.03.480_bib0024","doi-asserted-by":"crossref","first-page":"253","DOI":"10.1186\/s12967-014-0253-7","article-title":"Clinical observation of umbilical cord mesenchymal stem cell transplantation in treatment for sequelae of thoracolumbar spinal cord injury","volume":"12","author":"Cheng","year":"2014","journal-title":"J Transl Med"},{"key":"10.1016\/j.jcyt.2024.03.480_bib0025","doi-asserted-by":"crossref","first-page":"57","DOI":"10.1016\/j.jcyt.2020.09.012","article-title":"Repeated subarachnoid administrations of allogeneic human umbilical cord mesenchymal stem cells for spinal cord injury: a phase 1\/2 pilot study","volume":"23","author":"Yang","year":"2021","journal-title":"Cytotherapy"},{"issue":"9","key":"10.1016\/j.jcyt.2024.03.480_bib0026","doi-asserted-by":"crossref","first-page":"841","DOI":"10.2217\/rme-2018-0137","article-title":"An insight into the whole transcriptome profile of four tissue-specific human mesenchymal stem cells","volume":"14","author":"Alhattab","year":"2019","journal-title":"Regen Med"},{"issue":"5","key":"10.1016\/j.jcyt.2024.03.480_bib0027","doi-asserted-by":"crossref","first-page":"1499","DOI":"10.1007\/s11999-016-5133-4","article-title":"Classifications in brief: american spinal injury association (ASIA) impairment scale","volume":"475","author":"Roberts","year":"2017","journal-title":"Clin Orthop Relat Res"},{"key":"10.1016\/j.jcyt.2024.03.480_bib0028","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1186\/s13018-017-0689-6","article-title":"Intra-articular injection of expanded autologous bone marrow mesenchymal cells in moderate and severe knee osteoarthritis is safe: a phase I\/II study","volume":"12","author":"Al-Najar","year":"2017","journal-title":"J Orthop Surg Res"},{"issue":"3","key":"10.1016\/j.jcyt.2024.03.480_bib0029","doi-asserted-by":"crossref","first-page":"358","DOI":"10.1159\/000492120","article-title":"Safety and potential therapeutic effect of two intracavernous autologous bone marrow derived mesenchymal stem cells injections in diabetic patients with erectile dysfunction: an open label phase I clinical trial","volume":"101","author":"Al Demour","year":"2018","journal-title":"Urol Int"},{"issue":"3","key":"10.1016\/j.jcyt.2024.03.480_bib0030","doi-asserted-by":"crossref","first-page":"358","DOI":"10.1159\/000492120","article-title":"Safety and potential therapeutic effect of two intracavernous autologous bone marrow derived mesenchymal stem cells injections in diabetic patients with erectile dysfunction: an open label phase I clinical trial","volume":"101","author":"Al Demour","year":"2018","journal-title":"Urol Int"},{"issue":"5","key":"10.1016\/j.jcyt.2024.03.480_bib0031","doi-asserted-by":"crossref","first-page":"299","DOI":"10.2217\/rme-2021-0121","article-title":"Ultrasound-guided intra-articular injection of expanded umbilical cord mesenchymal stem cells in knee osteoarthritis: a safety\/efficacy study with MRI data","volume":"17","author":"Samara","year":"2022","journal-title":"Regen Med"},{"issue":"5","key":"10.1016\/j.jcyt.2024.03.480_bib0032","doi-asserted-by":"crossref","first-page":"e03929","DOI":"10.1016\/j.heliyon.2020.e03929","article-title":"Platelet lysate promotes the healing of long-standing diabetic foot ulcers: a report of two cases and in vitro study","volume":"6","author":"Jafar","year":"2020","journal-title":"Heliyon"},{"issue":"8","key":"10.1016\/j.jcyt.2024.03.480_bib0033","doi-asserted-by":"crossref","first-page":"3116","DOI":"10.1111\/iwj.14186","article-title":"Perilesional injections of human platelet lysate versus platelet poor plasma for the treatment of diabetic foot ulcers: a double-blinded prospective clinical trial","volume":"20","author":"Alhawari","year":"2023","journal-title":"Int Wound J"},{"key":"10.1016\/j.jcyt.2024.03.480_bib0034","first-page":"1","article-title":"Common terminology criteria for adverse events v3. 0","volume":"9","year":"2004","journal-title":"Int J Clin Oncol"},{"issue":"2","key":"10.1016\/j.jcyt.2024.03.480_bib0035","doi-asserted-by":"crossref","first-page":"1","DOI":"10.46292\/sci2702-1","article-title":"International standards for neurological classification of spinal cord injury: revised 2019","volume":"27","author":"Rupp","year":"2021","journal-title":"Top Spinal Cord Inj Rehabil"},{"key":"10.1016\/j.jcyt.2024.03.480_bib0036","first-page":"5251313","article-title":"Roles of mesenchymal stem cells in spinal cord injury. Stem","volume":"2017","author":"Qu","year":"2017","journal-title":"Cells Int"},{"issue":"10","key":"10.1016\/j.jcyt.2024.03.480_bib0037","doi-asserted-by":"crossref","first-page":"2676","DOI":"10.3390\/cells10102676","article-title":"Mechanisms of stem cell therapy in spinal cord injuries","volume":"10","author":"Shinozaki","year":"2021","journal-title":"Cells"},{"issue":"6","key":"10.1016\/j.jcyt.2024.03.480_bib0038","doi-asserted-by":"crossref","first-page":"1019","DOI":"10.3390\/cells11061019","article-title":"Clinical trials using mesenchymal stem cells for spinal cord injury: challenges in generating evidence","volume":"11","author":"de Ara\u00fajo","year":"2022","journal-title":"Cells"}],"container-title":["Cytotherapy"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S146532492400570X?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S146532492400570X?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2024,7,22]],"date-time":"2024-07-22T14:57:46Z","timestamp":1721660266000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S146532492400570X"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,8]]},"references-count":38,"journal-issue":{"issue":"8","published-print":{"date-parts":[[2024,8]]}},"alternative-id":["S146532492400570X"],"URL":"https:\/\/doi.org\/10.1016\/j.jcyt.2024.03.480","relation":{},"ISSN":["1465-3249"],"issn-type":[{"value":"1465-3249","type":"print"}],"subject":[],"published":{"date-parts":[[2024,8]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Safety and potential efficacy of expanded mesenchymal stromal cells of bone marrow and umbilical cord origins in patients with chronic spinal cord injuries: a phase I\/II study","name":"articletitle","label":"Article Title"},{"value":"Cytotherapy","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.jcyt.2024.03.480","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2024 International Society for Cell & Gene Therapy. Published by Elsevier Inc.","name":"copyright","label":"Copyright"}]}}